Document Type

Conference Proceeding

Abstract

  • ECMO is commonly used as a bridge to heart transplantation in critically ill patients.
  • Additional MCS devices (e.g., Impella, IABP) may be used alongside ECMO to enhance cardiac output.
  • The effect of dual circulatory support vs. ECMO alone on post-transplant survival is unclear especially after 2018, when the heart allocation system was revised to reduce waitlist times for MCS patients.

Publication Date

Spring 2025

Comments

Presented at American College of Cardiology, 2025

Share

COinS